Doxercalciferol
From Infogalactic: the planetary knowledge core
Names | |
---|---|
IUPAC name
(1S,3R,5Z,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraene-1,3-diol
|
|
Other names
1-Hydroxyergocalciferol; 1-Hydroxyvitamin D2; 1α-Hydroxyergocalciferol; 1α-Hydroxyvitamin D2; Hectorol; TSA 840
|
|
Identifiers | |
54573-75-0 | |
ChEMBL | ChEMBL1200810 |
ChemSpider | 4444554 |
DrugBank | DB06410 |
2790 | |
Jmol 3D model | Interactive image |
PubChem | 5281107 |
UNII | 3DIZ9LF5Y9 |
|
|
|
|
Properties | |
C28H44O2 | |
Molar mass | 412.66 g·mol−1 |
Pharmacology | |
ATC code | H05 |
Vapor pressure | {{{value}}} |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
verify (what is ?) | |
Infobox references | |
Doxercalciferol (trade name Hectorol) is drug for secondary hyperparathyroidism and metabolic bone disease.[1] It is a synthetic analog of ergocalciferol (vitamin D2). It suppresses parathyroid synthesis and secretion.[2]
References
<templatestyles src="Asbox/styles.css"></templatestyles>